On this page you can find relevant researchs on drug-related health topics, including HIV, hepatitis C, drug and overdose prevention, harm reduction and drug treatment. You can also find our Clinical Guidelines.

WHO: Guidance on Prevention of Viral Hepatitis B and C Among People Who Inject Drugs
This guidance is the first step in the provision of comprehensive guidance on viral hepatitis surveillance, prevention and treatment by the World Health Organization.
Drugs policy is AIDS policy
The Canadian Drug Policy Coalition (CDPC) details their vision and insights on the drug situation in Canada, including articles by Professor David Nutt, author of “Drugs- Without the Hot Air”; Dan Gardner, author of “Future Babble”; Dan Werb, Co-Founder, International Centre for Science in Drug Policy, and more.
AIDS 2012 Conference - Chris Ford
Chris Ford speaks at the IDHDP reception at the AIDS 2012 conference in Washington, on Can We Get to Zero Without Drug Policy Reform?
AIDS 2012 Conference - Stephen Lewis
Stephen Lewis talks at the IDHDP reception at the AIDS 2012 Conference "Can We Get to Zero Without Drug Policy Reform?"
We Can End AIDS 2012 March
Thousands of activists marched for human rights & economic justice on Tuesday 24th July from the venue of the International AIDS Conference, to the White House
Torture in the Name of Treatment: Asia Drug Detention
Human Rights Watch summarize HRW’s findings over five years of research on compulsory drug “treatment” centers in China, Cambodia, Vietnam, and Lao PDR.
Modelling potential impact of expanding access to anti-retroviral therapy on the concentrated HIV epidemic in Viet Nam
Presentation from Reuben Grannich from HIV/TB in the HIV/AIDS Department of WHO at the AIDS 2012 conference.
Prevention and care towards vulnerable and stigmatized populations (MSM, drug users, sex workers)
Presentation from Joseph Larmarange from the Centre Population and Devleopment (CEPED) at the AIDS 2012 Conference.
The Global Commission on HIV and the Law: A Movement for HIV Law Reform
This session addresses the political dimensions of the Commission's recommendations as an essential ingredient for successfully using the law to scale-up effective HIV responses.
Share this on: